Clinical pharmacology at the core of translational science

Expert Review of Clinical Pharmacology

Volumn 4, Issue 3, 2011, Pages 303-305

  Waldman, Scott A ^a   Terzic, Andre ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

clinical and translational science; enabling technologies; National Center for Advancing Translational Sciences; National Center for Clinical Research Resources

Indexed keywords

CLINICAL COMPETENCE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE; HEALTH CARE SYSTEM; HEALTH PRACTITIONER; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL RESEARCH; MEDICAL SOCIETY; PATIENT CARE; REVIEW;

ANIMALS; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); PHARMACOLOGY, CLINICAL; TRANSLATIONAL MEDICAL RESEARCH; UNITED STATES;

EID: 79955976759     PISSN: 17512433     EISSN: 17512441     Source Type: Journal    
DOI: 10.1586/ecp.11.8     Document Type: Review

References (19)

1. Waldman SA, Terzic A. Translational medicine in the era of health care reform. Clin. Transl. Sci. 2(2), 96-97 (2009).
2. Waldman SA, Terzic A. Molecular therapeutics from knowledge to delivery. Clin. Pharmacol. Ther. 87(6), 619-623 (2010).
3. Kaiser J. National Institutes of Health. A government niche for translational medicine and drug development. Science 330(6010), 1462-1463 (2010).
4. Waldman SA, Terzic A. Clinical translational science 2020: disruptive innovation redefines the discovery-application enterprise. Clin. Transl. Sci. 4(1), 69-71 (2011).
5. Honig PK. Comparative effectiveness: the fourth hurdle in drug development and a role for clinical pharmacology. Clin. Pharmacol. Ther. 89(2), 151-156 (2011).
6. Butler D. Translational research: crossing the valley of death. Nature 453(7197), 840-842 (2008). (Pubitemid 351832542)
7. Clancy C, Collins FS. Patient-Centered Outcomes Research Institute: the intersection of science and health care. Sci. Transl. Med. 2(37), 37cm18 (2010).
8. Waldman SA, Terzic A. Molecular therapy drives patient-centric health care paradigms. Clin. Transl. Sci. 3(4), 170-171 (2010).
9. Skarke C, Fitzgerald GA. Training translators for smart drug discovery. Sci. Transl. Med. 2(26), 26cm12 (2010).
10. Fitzgerald G. Drug development needs a new brand of science. Nature 468(7326), 869 (2010).
11. Fitzgerald GA. Clinical pharmacology or translational medicine and therapeutics: reinvent or rebrand and expand? Clin. Pharmacol. Ther. 81(1), 19-20 (2007).
12. Waldman SA, Kraft WK, Nelson TJ, Terzic A. Clinical pharmacology: a paradigm for individualized medicine. Biomark. Med. 3(6), 679-684 (2009).
13. Waldman SA, Terzic A. Clinical and translational science: from bench-bedside to global village. Clin. Transl. Sci. 3(5), 254-257 (2010).
14. Dollery CT. The scientific contribution of clinical pharmacology. Eur. J. Clin. Pharmacol. 64(2), 99-106 (2008).
15. Waldman SA, Christensen NB, Moore JE, Terzic A. Clinical pharmacology: the science of therapeutics. Clin. Pharmacol. Ther. 81(1), 3-6 (2007). (Pubitemid 46050856)
16. Giacomini KM, Brett CM, Altman RB et al. The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin. Pharmacol. Ther. 81(3), 328-345 (2007). (Pubitemid 46364488)
17. Lesko LJ. Paving the critical path: how can clinical pharmacology help achieve the vision? Clin. Pharmacol. Ther. 81(2), 170-177 (2007). (Pubitemid 46174813)
18. Maxwell SR, Webb DJ. Clinical pharmacology - too young to die? Lancet 367(9513), 799-800 (2006). (Pubitemid 43363353)
19. Wadman M. The bridge between lab and clinic. Nature 468, 877 (2010).